Visiopharm Ki-67 for Breast Cancer

Visiopharm logo

The Ki-67 protein is associated with cellular proliferation and can be assessed by Ki-67-immunohistochemical (IHC) staining. The calculated proliferation index can be correlated to the tumor grade and the clinical course.

The Ki-67 solution is fully automated and does not require manual input during analysis. The solution consists of four automated analysis steps. Once started, it automatically separates the sample tissue from control tissues and robustly identifies invasive cancer areas in the sample. Tumor nuclei are counted based on their Ki-67 expression and the resulting proliferation index for the whole tumor area is calculated.

Reviews

There are no reviews yet.

Be the first to review “Visiopharm Ki-67 for Breast Cancer”

Your email address will not be published. Required fields are marked *

3 × 4 =

Have you considered:

  • Indica Labs - Digital Pathology

  • Tribun Health - Digital Pathology

  • PAIGE DIGITAL PATHOLOGY VIEWER

  • Tribun Health - Digital Pathology

Get Pathology News Delivered to Your Inbox

News